Can Only Partial T-Cell Depletion of the Graft before Hematopoietic Stem Cell Transplantation Mitigate Graft-versus-Host Disease While Preserving a Graft-versus-Leukemia Reaction? A Prospective Phase II Study-Reference-Cited by-同舟云学术

Can Only Partial T-Cell Depletion of the Graft before Hematopoietic Stem Cell Transplantation Mitigate Graft-versus-Host Disease While Preserving a Graft-versus-Leukemia Reaction? A Prospective Phase II Study

Published:2006-01 Issue:1 Volume:12 Page:102-110
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Chalandon Yves,Roosnek Eddy,Mermillod Bernadette,Waelchli Laurent,Helg Claudine,Chapuis Bernard

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference63 articles.

1. Bone marrow transplantation;Armitage;N Engl J Med,1994

3. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase;Clift;Blood,1991

4. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission;Clift;Blood,1990

5. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome;Anderson;Blood,1993

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted Grafts;Transplantation and Cellular Therapy;2021-01

2. Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell Transplantation;Frontiers in Immunology;2020-05-27

3. Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation;Leukemia;2019-11-26

4. Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation;Frontiers in Immunology;2019-05-16

5. Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome;Bone Marrow Transplantation;2018-03-07